< Back to previous page
Researcher
Sabine Tejpar
- Disciplines:Oncology
Affiliations
- Digestive Oncology (Division)
Responsible
From1 Aug 2022 → Today - Digestive Oncology (Division)
Member
From1 Aug 2022 → Today - Molecular Digestive Oncology (Division)
Member
From1 Jan 2012 → 31 Jul 2022 - Translational Research in GastroIntestinal Disorders (Division)
Member
From1 Oct 2003 → 31 Dec 2011
Projects
1 - 10 of 56
- Querying and exploiting the spatial colorectal tumor ecosystem for novel biological, diagnostic and therapeutic insightsFrom23 Nov 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The evolutionary landscape of colorectal cancer, from polyp to metastasisFrom25 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Optimizing a high throughput TCR-epitope recognition tool to characterize microbiome specific TCR interactions in colorectal cancerFrom1 Oct 2023 → TodayFunding: BOF - doctoral mandates
- Non-genetic drivers of YAP activation in colorectal cancerFrom26 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Study the efficacy and mechanism of targeted TIM3 and VISTA in the treatment of gastroesophageal junction / gastric cancer patients with low immunogenicity and FLOT chemotherapy resistanceFrom14 Feb 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Using mucins as friends in colorectal cancer diagnostics and treatmentFrom1 Jan 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Infrastructure for Targeted ProteomicsFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Unique IsoPlexis technology for multiplexed single cell functional profilingFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Querying and exploiting the spatial colorectal tumor ecosystem for novel biological, diagnostic and therapeutic insightsFrom1 Oct 2022 → TodayFunding: BOF - projects, Fund Recuperation Fiscal Exemption
- Coevolution of epithelium in colorectal cancer: comprehensive characterization of progress-associated tumor heterogeneity in the colorectal cancerFrom1 Oct 2022 → TodayFunding: FWO junior postdoctoral fellowship
Publications
221 - 230 of 250
- MOLECULAR AND CLINICAL DETERMINANTS OF SURVIVAL FOLLOWING RELAPSE AFTER TREATMENT OF STAGE II-III COLON CANCER (CC). RESULTS OF THE TRANSLATIONAL STUDY ON THE PETACC 3-EORTC 40993-SAKK 60-00 TRIAL(2010)
Authors: Eric Van Cutsem, Sabine Tejpar
Pages: 16 - 16 - MUTANT KRAS AND BRAF GENE EXPRESSION PROFILES IN COLORECTAL CANCER: RESULTS OF THE TRANSLATIONAL STUDY ON THE PETACC 3-EORTC 40993-SAKK 60-00 TRIAL(2010)
Authors: Sabine Tejpar, Eric Van Cutsem
Pages: 17 - 17 - Improved first-line chemotherapy: a better chance for surgery?(2010)
Authors: Sabine Tejpar, Eric Van Cutsem
Pages: 4 - 5 - Implications of KRAS mutation status for the treatment of metastatic colorectal cancer(2009)
Authors: Sabine Tejpar
Pages: 311 - 322 - Amphiregulin and epiregulin mRNA expression in primary tumors predicts outcome in metastatic colorectal cancer treated with cetuximab(2009)
Authors: Bart Jacobs, Wendy De Roock, Robin Van Oirbeek, Steffen Fieuws, Gert De Hertogh, Eric Van Cutsem, Sabine Tejpar
Pages: 5068 - 5074 - Tissue biomarker development in a multicentre trial context: a feasibility study on the PETACC3 stage II and III colon cancer adjuvant treatment trial(2009)
Authors: Sabine Tejpar, Eric Van Cutsem
Pages: 5528 - 5533 - Skin toxicities of targeted therapies(2009)
Authors: Siegfried Segaert, Eric Van Cutsem, Sabine Tejpar
Pages: 295 - 308 - Impact of molecular markers on treatment selection in advanced colorectal cancer(2009)
Authors: Hans Prenen, Sabine Tejpar, Eric Van Cutsem
Pages: 70 - 8 - Accomplishments in 2008 in biologic markers for gastrointestinal cancers-focus on colorectal cancer(2009)
Authors: Sabine Tejpar
Pages: S73 - S78 - Implications for KRAS status and EGFR-targeted therapies in metastatic CRC(2009)
Authors: Sabine Tejpar, Eric Van Cutsem
Pages: 519 - 527
Patents
1 - 1 of 1
- Colon cancer (Inventor)